CAMZYOS

Product NDC: 73625-112
11-digit product format: 736250112
Labeler code: 73625
Product ID: 73625-112_85338960-904b-44df-908f-b74b62902779
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: mavacamten
Dosage form: CAPSULE, GELATIN COATED
Route: ORAL
Labeler: Myokardia, Inc.
Application: NDA214998
Marketing category: NDA
Marketing start: 2022-04-28
Substance: MAVACAMTEN
Active strength: 5 mg/1
Pharmacologic classes: Cardiac Myosin Inhibitor [EPC], Cardiac Myosin Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	RLD / RS	Approval date
N214998-001	CAMZYOS	MAVACAMTEN	2.5MG	CAPSULE / ORAL	RLD	2022-04-28
N214998-002	CAMZYOS	MAVACAMTEN	5MG	CAPSULE / ORAL	RLD, RS	2022-04-28
N214998-003	CAMZYOS	MAVACAMTEN	10MG	CAPSULE / ORAL	RLD	2022-04-28
N214998-004	CAMZYOS	MAVACAMTEN	15MG	CAPSULE / ORAL	RLD	2022-04-28

Orange Book patents#

Current patent rows page 1 of 1 · 8 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N214998-001	9585883	2034-06-19	U-3373		2022-05-26
N214998-001	RE50050	2036-04-28		Drug substance, Drug product	2024-08-20
N214998-002	9585883	2034-06-19	U-3373		2022-05-26
N214998-002	RE50050	2036-04-28		Drug substance, Drug product	2024-08-20
N214998-003	9585883	2034-06-19	U-3373		2022-05-26
N214998-003	RE50050	2036-04-28		Drug substance, Drug product	2024-08-20
N214998-004	9585883	2034-06-19	U-3373		2022-05-26
N214998-004	RE50050	2036-04-28		Drug substance, Drug product	2024-08-20

Orange Book exclusivity#

Current exclusivity rows page 1 of 1 · 12 matching rows.

Application-product, Exclusivity code, Expiration table
Application-product	Exclusivity code	Expiration
N214998-001	M-297	2026-06-15
N214998-001	NCE	2027-04-28
N214998-001	ODE-398	2029-04-28
N214998-002	M-297	2026-06-15
N214998-002	NCE	2027-04-28
N214998-002	ODE-398	2029-04-28
N214998-003	M-297	2026-06-15
N214998-003	NCE	2027-04-28
N214998-003	ODE-398	2029-04-28
N214998-004	M-297	2026-06-15
N214998-004	NCE	2027-04-28
N214998-004	ODE-398	2029-04-28

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 124 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	N214998-001	CAMZYOS	2.5MG	CAPSULE / ORAL	RLD	2022-04-28	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N214998-002	CAMZYOS	5MG	CAPSULE / ORAL	RLD, RS	2022-04-28	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N214998-003	CAMZYOS	10MG	CAPSULE / ORAL	RLD	2022-04-28	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N214998-004	CAMZYOS	15MG	CAPSULE / ORAL	RLD	2022-04-28	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N214998-001	CAMZYOS	2.5MG	CAPSULE / ORAL	RLD	2022-04-28	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N214998-002	CAMZYOS	5MG	CAPSULE / ORAL	RLD, RS	2022-04-28	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N214998-003	CAMZYOS	10MG	CAPSULE / ORAL	RLD	2022-04-28	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N214998-004	CAMZYOS	15MG	CAPSULE / ORAL	RLD	2022-04-28	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N214998-001	CAMZYOS	2.5MG	CAPSULE / ORAL	RLD	2022-04-28	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N214998-002	CAMZYOS	5MG	CAPSULE / ORAL	RLD, RS	2022-04-28	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N214998-003	CAMZYOS	10MG	CAPSULE / ORAL	RLD	2022-04-28	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N214998-004	CAMZYOS	15MG	CAPSULE / ORAL	RLD	2022-04-28	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N214998-001	CAMZYOS	2.5MG	CAPSULE / ORAL	RLD	2022-04-28	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N214998-002	CAMZYOS	5MG	CAPSULE / ORAL	RLD, RS	2022-04-28	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N214998-003	CAMZYOS	10MG	CAPSULE / ORAL	RLD	2022-04-28	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N214998-004	CAMZYOS	15MG	CAPSULE / ORAL	RLD	2022-04-28	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N214998-001	CAMZYOS	2.5MG	CAPSULE / ORAL	RLD	2022-04-28	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N214998-002	CAMZYOS	5MG	CAPSULE / ORAL	RLD, RS	2022-04-28	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N214998-003	CAMZYOS	10MG	CAPSULE / ORAL	RLD	2022-04-28	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N214998-004	CAMZYOS	15MG	CAPSULE / ORAL	RLD	2022-04-28	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N214998-001	CAMZYOS	2.5MG	CAPSULE / ORAL	RLD	2022-04-28	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N214998-002	CAMZYOS	5MG	CAPSULE / ORAL	RLD, RS	2022-04-28	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N214998-003	CAMZYOS	10MG	CAPSULE / ORAL	RLD	2022-04-28	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N214998-004	CAMZYOS	15MG	CAPSULE / ORAL	RLD	2022-04-28	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N214998-001	CAMZYOS	2.5MG	CAPSULE / ORAL	RLD	2022-04-28	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N214998-002	CAMZYOS	5MG	CAPSULE / ORAL	RLD, RS	2022-04-28	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N214998-003	CAMZYOS	10MG	CAPSULE / ORAL	RLD	2022-04-28	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N214998-004	CAMZYOS	15MG	CAPSULE / ORAL	RLD	2022-04-28	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N214998-001	CAMZYOS	2.5MG	CAPSULE / ORAL	RLD	2022-04-28	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N214998-002	CAMZYOS	5MG	CAPSULE / ORAL	RLD, RS	2022-04-28	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N214998-003	CAMZYOS	10MG	CAPSULE / ORAL	RLD	2022-04-28	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N214998-004	CAMZYOS	15MG	CAPSULE / ORAL	RLD	2022-04-28	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N214998-001	CAMZYOS	2.5MG	CAPSULE / ORAL	RLD	2022-04-28	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N214998-002	CAMZYOS	5MG	CAPSULE / ORAL	RLD, RS	2022-04-28	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N214998-003	CAMZYOS	10MG	CAPSULE / ORAL	RLD	2022-04-28	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N214998-004	CAMZYOS	15MG	CAPSULE / ORAL	RLD	2022-04-28	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N214998-001	CAMZYOS	2.5MG	CAPSULE / ORAL	RLD	2022-04-28	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N214998-002	CAMZYOS	5MG	CAPSULE / ORAL	RLD, RS	2022-04-28	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N214998-003	CAMZYOS	10MG	CAPSULE / ORAL	RLD	2022-04-28	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N214998-004	CAMZYOS	15MG	CAPSULE / ORAL	RLD	2022-04-28	`5bbf6a4d5a75…`

Observed Orange Book patent history#

Patent history page 1 of 7 · 248 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2026-09-14 22:38:34	2026-08	N214998-001	9585883	2034-06-19	U-3373		2022-05-26	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N214998-001	RE50050	2036-04-28		Drug substance, Drug product	2024-08-20	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N214998-002	9585883	2034-06-19	U-3373		2022-05-26	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N214998-002	RE50050	2036-04-28		Drug substance, Drug product	2024-08-20	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N214998-003	9585883	2034-06-19	U-3373		2022-05-26	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N214998-003	RE50050	2036-04-28		Drug substance, Drug product	2024-08-20	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N214998-004	9585883	2034-06-19	U-3373		2022-05-26	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N214998-004	RE50050	2036-04-28		Drug substance, Drug product	2024-08-20	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N214998-001	9585883	2034-06-19	U-3373		2022-05-26	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N214998-001	RE50050	2036-04-28		Drug substance, Drug product	2024-08-20	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N214998-002	9585883	2034-06-19	U-3373		2022-05-26	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N214998-002	RE50050	2036-04-28		Drug substance, Drug product	2024-08-20	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N214998-003	9585883	2034-06-19	U-3373		2022-05-26	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N214998-003	RE50050	2036-04-28		Drug substance, Drug product	2024-08-20	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N214998-004	9585883	2034-06-19	U-3373		2022-05-26	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N214998-004	RE50050	2036-04-28		Drug substance, Drug product	2024-08-20	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N214998-001	9585883	2034-06-19	U-3373		2022-05-26	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N214998-001	RE50050	2036-04-28		Drug substance, Drug product	2024-08-20	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N214998-002	9585883	2034-06-19	U-3373		2022-05-26	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N214998-002	RE50050	2036-04-28		Drug substance, Drug product	2024-08-20	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N214998-003	9585883	2034-06-19	U-3373		2022-05-26	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N214998-003	RE50050	2036-04-28		Drug substance, Drug product	2024-08-20	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N214998-004	9585883	2034-06-19	U-3373		2022-05-26	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N214998-004	RE50050	2036-04-28		Drug substance, Drug product	2024-08-20	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N214998-001	9585883	2034-06-19	U-3373		2022-05-26	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N214998-001	RE50050	2036-04-28		Drug substance, Drug product	2024-08-20	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N214998-002	9585883	2034-06-19	U-3373		2022-05-26	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N214998-002	RE50050	2036-04-28		Drug substance, Drug product	2024-08-20	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N214998-003	9585883	2034-06-19	U-3373		2022-05-26	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N214998-003	RE50050	2036-04-28		Drug substance, Drug product	2024-08-20	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N214998-004	9585883	2034-06-19	U-3373		2022-05-26	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N214998-004	RE50050	2036-04-28		Drug substance, Drug product	2024-08-20	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N214998-001	9585883	2034-06-19	U-3373		2022-05-26	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N214998-001	RE50050	2034-06-19		Drug substance, Drug product	2024-08-20	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N214998-002	9585883	2034-06-19	U-3373		2022-05-26	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N214998-002	RE50050	2034-06-19		Drug substance, Drug product	2024-08-20	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N214998-003	9585883	2034-06-19	U-3373		2022-05-26	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N214998-003	RE50050	2034-06-19		Drug substance, Drug product	2024-08-20	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N214998-004	9585883	2034-06-19	U-3373		2022-05-26	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N214998-004	RE50050	2034-06-19		Drug substance, Drug product	2024-08-20	`6a471c1ec25d…`

Observed Orange Book exclusivity history#

Exclusivity history page 1 of 8 · 312 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Exclusivity code	Expiration	Source SHA-256
2026-09-14 22:38:34	2026-08	N214998-001	M-297	2026-06-15	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N214998-001	NCE	2027-04-28	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N214998-001	ODE-398	2029-04-28	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N214998-002	M-297	2026-06-15	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N214998-002	NCE	2027-04-28	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N214998-002	ODE-398	2029-04-28	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N214998-003	M-297	2026-06-15	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N214998-003	NCE	2027-04-28	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N214998-003	ODE-398	2029-04-28	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N214998-004	M-297	2026-06-15	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N214998-004	NCE	2027-04-28	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N214998-004	ODE-398	2029-04-28	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N214998-001	M-297	2026-06-15	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N214998-001	NCE	2027-04-28	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N214998-001	ODE-398	2029-04-28	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N214998-002	M-297	2026-06-15	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N214998-002	NCE	2027-04-28	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N214998-002	ODE-398	2029-04-28	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N214998-003	M-297	2026-06-15	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N214998-003	NCE	2027-04-28	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N214998-003	ODE-398	2029-04-28	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N214998-004	M-297	2026-06-15	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N214998-004	NCE	2027-04-28	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N214998-004	ODE-398	2029-04-28	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N214998-001	M-297	2026-06-15	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N214998-001	NCE	2027-04-28	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N214998-001	ODE-398	2029-04-28	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N214998-002	M-297	2026-06-15	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N214998-002	NCE	2027-04-28	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N214998-002	ODE-398	2029-04-28	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N214998-003	M-297	2026-06-15	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N214998-003	NCE	2027-04-28	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N214998-003	ODE-398	2029-04-28	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N214998-004	M-297	2026-06-15	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N214998-004	NCE	2027-04-28	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N214998-004	ODE-398	2029-04-28	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N214998-001	M-297	2026-06-15	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N214998-001	NCE	2027-04-28	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N214998-001	ODE-398	2029-04-28	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N214998-002	M-297	2026-06-15	`31067a03dcf5…`

Additional Listing Data#

Finished product: Yes
Brand name base: CAMZYOS
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
MAVACAMTEN	5 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
QX45B99R3J	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 8 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
2600872	Internal RxNorm lookup
2600878	Internal RxNorm lookup
2600880	Internal RxNorm lookup
2600882	Internal RxNorm lookup
2600884	Internal RxNorm lookup
2600886	Internal RxNorm lookup
2600888	Internal RxNorm lookup
2600890	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
669c936b-3ee6-4e36-8a22-79dd11b1255b	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
0a13c384-d0ea-416d-b216-1252390cf5b8	Product name	1	20230113

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
73625-112-11	CAMZYOS	30 in 1 BOTTLE, PLASTIC	CAPSULE, GELATIN COATED	30		8

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
73625-112-11	EA - Each	73625-112	de22be91-e7fe-4506-b331-1a9743438e2b	1	2022-06-06

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
73625-112	CAMZYOS (MAVACAMTEN) CAPSULE, GELATIN COATED [MYOKARDIA, INC.]	8	Current NDC, Legacy NDC, 1 package rows	20250501_669c936b-3ee6-4e36-8a22-79dd11b1255b.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
CAMZYOS	MAVACAMTEN	Myokardia, Inc.	669c936b-3ee6-4e36-8a22-79dd11b1255b	2025-04-17	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 214998 application number: NDA214998 ndc (product): 73625-112

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
QX45B99R3J	MAVACAMTEN	1642288-47-8	MAVACAMTEN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
2600878	CAMZYOS 10 MG Oral Capsule	PSN	669c936b-3ee6-4e36-8a22-79dd11b1255b	8
2600882	CAMZYOS 15 MG Oral Capsule	PSN	669c936b-3ee6-4e36-8a22-79dd11b1255b	8
2600886	CAMZYOS 2.5 MG Oral Capsule	PSN	669c936b-3ee6-4e36-8a22-79dd11b1255b	8
2600890	CAMZYOS 5 MG Oral Capsule	PSN	669c936b-3ee6-4e36-8a22-79dd11b1255b	8
2600872	mavacamten 10 MG Oral Capsule	PSN	669c936b-3ee6-4e36-8a22-79dd11b1255b	8
2600880	mavacamten 15 MG Oral Capsule	PSN	669c936b-3ee6-4e36-8a22-79dd11b1255b	8
2600884	mavacamten 2.5 MG Oral Capsule	PSN	669c936b-3ee6-4e36-8a22-79dd11b1255b	8
2600888	mavacamten 5 MG Oral Capsule	PSN	669c936b-3ee6-4e36-8a22-79dd11b1255b	8
2600878	mavacamten 10 MG Oral Capsule [Camzyos]	SBD	669c936b-3ee6-4e36-8a22-79dd11b1255b	8
2600882	mavacamten 15 MG Oral Capsule [Camzyos]	SBD	669c936b-3ee6-4e36-8a22-79dd11b1255b	8
2600886	mavacamten 2.5 MG Oral Capsule [Camzyos]	SBD	669c936b-3ee6-4e36-8a22-79dd11b1255b	8
2600890	mavacamten 5 MG Oral Capsule [Camzyos]	SBD	669c936b-3ee6-4e36-8a22-79dd11b1255b	8
2600872	mavacamten 10 MG Oral Capsule	SCD	669c936b-3ee6-4e36-8a22-79dd11b1255b	8
2600880	mavacamten 15 MG Oral Capsule	SCD	669c936b-3ee6-4e36-8a22-79dd11b1255b	8
2600884	mavacamten 2.5 MG Oral Capsule	SCD	669c936b-3ee6-4e36-8a22-79dd11b1255b	8
2600888	mavacamten 5 MG Oral Capsule	SCD	669c936b-3ee6-4e36-8a22-79dd11b1255b	8
2600878	Camzyos 10 MG Oral Capsule	SY	669c936b-3ee6-4e36-8a22-79dd11b1255b	8
2600882	Camzyos 15 MG Oral Capsule	SY	669c936b-3ee6-4e36-8a22-79dd11b1255b	8
2600886	Camzyos 2.5 MG Oral Capsule	SY	669c936b-3ee6-4e36-8a22-79dd11b1255b	8
2600890	Camzyos 5 MG Oral Capsule	SY	669c936b-3ee6-4e36-8a22-79dd11b1255b	8

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
73625-112-11	73625011211	30 CAPSULE, GELATIN COATED in 1 BOTTLE, PLASTIC (73625-112-11)	2022-04-28	0000-00-00	No	No	Current